# Catheter-Related Early Thromboprophylaxis With Enoxaparin (CRETE) Trial

> **NCT03003390** · PHASE2 · TERMINATED · sponsor: **Yale University** · enrollment: 51 (actual)

## Conditions studied

- Deep Venous Thrombosis

## Interventions

- **DRUG:** Enoxaparin

## Key facts

- **NCT ID:** NCT03003390
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-04-05
- **Primary completion:** 2019-08-16
- **Final completion:** 2019-08-16
- **Target enrollment:** 51 (ACTUAL)
- **Why stopped:** Met protocol defined stopping rule for futility
- **Last updated:** 2020-07-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03003390

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03003390, "Catheter-Related Early Thromboprophylaxis With Enoxaparin (CRETE) Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03003390. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*